USPTO serial 99291734
VIOLET
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- KOVALSKY, LAURA G
- Law office
- TMO LAW OFFICE 110
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with VIOLET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew T. Pettit
Andrew T. Pettit Ashurst Perkins Coie US LLPP.O. Box 2608Seattle, WA 98111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; Downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; Downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; Downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; Downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; Downloadable application programming interface (API) software; Downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields | ACTIVE | — |
| 038 | Telecommunications services in the nature of transmission of voice, data, graphics, images, audio and video by means of telecommunications networks, wireless communication networks, and the internet; telecommunications platform related to health, namely, transmission of voice, data, graphics, images, audio and video related to health by means of telecommunications networks, wireless communication networks, and the internet; Providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data | ACTIVE | — |
| 042 | Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software using for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields | ACTIVE | — |
| 044 | Healthcare services in the nature of real time medical diagnosis support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VERILY HEALTH INC.
- Other trademarks owned by Verily Life Sciences LLC
- Other trademarks in Class 009
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VIOLET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 17, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 10, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 22, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 22, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 22, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 1, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 1, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Nov 14, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 18, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 18, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2025 | NWAP | NEW APPLICATION ENTERED | — |